Redefining Longevity and Cancer Care with Precision Drug Delivery

Advanced AI-Driven Therapeutics for Targeted, High-Impact Healthcare Solutions

Explore Our Technology

Focused on Therapeutic Areas for Longevity and Oncology

Organ-Specific Therapies

Targeted treatments for organs most affected by aging, designed to support their health and longevity.

Organ-Specific Therapies

Targeted treatments for organs most affected by aging, designed to support their health and longevity.

Organ-Specific Therapies

Targeted treatments for organs most affected by aging, designed to support their health and longevity.

Oncology - Cancer Cell Targeting

AI-driven therapies specifically designed to address cancer cells with minimal impact on surrounding healthy tissue.

Oncology - Cancer Cell Targeting

AI-driven therapies specifically designed to address cancer cells with minimal impact on surrounding healthy tissue.

Oncology - Cancer Cell Targeting

AI-driven therapies specifically designed to address cancer cells with minimal impact on surrounding healthy tissue.

Anti-Inflammatory Response

Reducing inflammation, a key driver of aging and many age-related diseases, to improve quality of life and extend healthspan.

Anti-Inflammatory Response

Reducing inflammation, a key driver of aging and many age-related diseases, to improve quality of life and extend healthspan.

Anti-Inflammatory Response

Reducing inflammation, a key driver of aging and many age-related diseases, to improve quality of life and extend healthspan.

Cellular Regeneration

Therapies that enhance the body’s natural ability to repair and regenerate tissues, supporting long-term health outcomes.

Cellular Regeneration

Therapies that enhance the body’s natural ability to repair and regenerate tissues, supporting long-term health outcomes.

Cellular Regeneration

Therapies that enhance the body’s natural ability to repair and regenerate tissues, supporting long-term health outcomes.

Care

Your Well-Being is Our Priority

Be part of the revolution

Together, we are pioneering the future of healthcare with a focus on collaboration and scientific rigor.

Be part of the revolution

Together, we are pioneering the future of healthcare with a focus on collaboration and scientific rigor.

Be part of the revolution

Together, we are pioneering the future of healthcare with a focus on collaboration and scientific rigor.

Future Dynamic Medicine (FDM)

is advancing healthcare through a proprietary drug delivery platform that integrates artificial intelligence to tackle complex therapeutic needs in longevity and oncology.

Future Dynamic Medicine (FDM)

is advancing healthcare through a proprietary drug delivery platform that integrates artificial intelligence to tackle complex therapeutic needs in longevity and oncology.

Future Dynamic Medicine (FDM)

is advancing healthcare through a proprietary drug delivery platform that integrates artificial intelligence to tackle complex therapeutic needs in longevity and oncology.

Our AI-driven technology

precisely targets specific organs and cancer cells with custom-selected binders, maximizing therapeutic impact while minimizing off-target effects.

Our AI-driven technology

precisely targets specific organs and cancer cells with custom-selected binders, maximizing therapeutic impact while minimizing off-target effects.

Our AI-driven technology

precisely targets specific organs and cancer cells with custom-selected binders, maximizing therapeutic impact while minimizing off-target effects.

The Science

The Science Behind FDM Section

Harnessing AI and Advanced Delivery Systems to Maximize Therapeutic Efficacy

FDM’s scientific approach combines biotechnology with AI-powered binder selection, optimizing drug delivery to precisely target and affect specific cells and organs.

Learn More

Science-Driven Precision for Targeted Therapeutics

Explore the comprehensive features that set Arise apart in web design excellence.

Our Proprietary Drug Delivery Platform

Transforming Therapeutic Precision with AI-Optimized Targeting

FDM’s proprietary drug delivery platform is designed to overcome the limitations of conventional therapies by using AI-selected binders and targeted release mechanisms. This system ensures that each therapeutic agent is transported directly to its intended site, reducing degradation and maximizing potency at the cellular level. Optimized for both longevity and oncology, our platform delivers high-impact, targeted healthcare solutions that address some of the most pressing needs in modern medicine.

AI-Powered Analysis

Our proprietary AI algorithms assess millions of molecular interactions

AI-Powered Analysis

Our proprietary AI algorithms assess millions of molecular interactions

AI-Powered Analysis

Our proprietary AI algorithms assess millions of molecular interactions

Precision Targeting

Optimized binder selection ensures accurate therapeutic delivery

Precision Targeting

Optimized binder selection ensures accurate therapeutic delivery

Precision Targeting

Optimized binder selection ensures accurate therapeutic delivery

Maximum Impact

Enhanced efficacy with minimal side effects through precise targeting

Maximum Impact

Enhanced efficacy with minimal side effects through precise targeting

Maximum Impact

Enhanced efficacy with minimal side effects through precise targeting

Team

Our Leadership and Expertise

Dr. Francisco Diaz-Mitoma, PhD, MD, FRCPC

CEO & Co-founder

An accomplished clinical scientist and entrepreneur, Dr. Diaz-Mitoma founded FDM to address complex healthcare needs in longevity and oncology. With extensive experience in drug development and precision medicine, he leads FDM’s strategic vision.

Dr. Francisco Diaz-Mitoma, PhD, MD, FRCPC

CEO & Co-founder

Dr. Francisco Diaz-Mitoma, PhD, MD, FRCPC

CEO & Co-founder

Dr. Rohan Lalani, PhD

Senior Scientist

Dr. Lalani brings a strong background in molecular biology and bioinformatics to FDM’s research team. His expertise in molecular targeting strengthens FDM’s commitment to scientific precision.

Dr. Rohan Lalani, PhD

Senior Scientist

Dr. Lalani brings a strong background in molecular biology and bioinformatics to FDM’s research team. His expertise in molecular targeting strengthens FDM’s commitment to scientific precision.

Dr. Rohan Lalani, PhD

Senior Scientist

Dr. Lalani brings a strong background in molecular biology and bioinformatics to FDM’s research team. His expertise in molecular targeting strengthens FDM’s commitment to scientific precision.

Jasminka Bozic, Master in Science

Director of Manufacturing

Jasminka oversees FDM’s manufacturing operations, ensuring quality and efficiency in drug production to meet industry standards.

Jasminka Bozic, Master in Science

Director of Manufacturing

Jasminka oversees FDM’s manufacturing operations, ensuring quality and efficiency in drug production to meet industry standards.

Jasminka Bozic, Master in Science

Director of Manufacturing

Jasminka oversees FDM’s manufacturing operations, ensuring quality and efficiency in drug production to meet industry standards.

Meet other team members

Redefining Longevity and Cancer Care with Precision Drug Delivery